Navigating the complexities of healthcare billing can be challenging, especially when it comes to laboratory and EKG claims submitted on the CMS 1500 form. Accurate billing is crucial for prompt reimbursement and to avoid common denials like MA114 and N286. This comprehensive guide provides expert tips to master CMS 1500 billing for lab services, EKG co-billing, and understanding Medicare’s critical medical necessity requirements.
Beyond Form Fields: Medicare Medical Necessity for Laboratory Claims
Successfully completing the CMS 1500 form is just one piece of the puzzle. For Medicare claims, every billed service must also meet specific medical necessity criteria, as outlined in National Coverage Determinations (NCDs) or Local Coverage Determinations (LCDs). Failing to meet these criteria, even with a perfectly filled form, can lead to claim denials. Medicare’s NCDs provide detailed guidelines on when certain lab tests are considered reasonable and necessary.
Key Medicare National Coverage Determinations (NCDs) for Lab Services
- Glycated Hemoglobin/Glycated Protein (NCD 190.21): Testing is generally covered for diabetic patients no more often than every three months if the patient is controlled, or monthly for pregnant diabetic women. More frequent testing requires specific medical necessity documentation outlining the clinical rationale. Without this, claims may be denied. For more details, refer to the NCD 190.21 on cms.gov.
- Thyroid Testing (NCD 190.22): For clinically stable patients, follow-up thyroid testing is typically covered up to two times per year. More frequent testing necessitates documented symptoms, altered therapy, or other clear medical indications. Consult the NCD 190.22 on cms.gov for full guidelines.
- Lipid Testing (NCD 190.23): Lipid panels are medically necessary for evaluating atherosclerotic cardiovascular disease and certain metabolic disorders. Frequency limitations apply for monitoring dietary or pharmacologic therapy, often annually, or up to six times in the first year for therapy initiation/adjustment. Detailed information is available in the NCD 190.23 on cms.gov.
- Other pertinent NCDs include Digoxin Therapeutic Drug Assay (NCD 190.24) and Carcinoembryonic Antigen (NCD 190.26), each with specific coverage criteria that providers must follow.
Understanding Common CMS 1500 Denials for Lab Claims
Remark Code MA114: Missing or Incorrect Service Location/Performing Provider Details
What Triggers MA114: This denial occurs when critical information about where the lab test was performed is missing or incorrect in Item 32 of the CMS 1500 form. It also applies if, for anti-markup services, the performing physician’s or supplier’s NPI is missing in Item 32a, along with their name and address in Item 32.
Common Scenarios:
- Failing to enter the name, address, and ZIP Code of the service location in Item 32 when services are performed outside the patient’s home (place of service 12) or the physician’s office.
- For diagnostic services purchased from another billing jurisdiction (anti-markup services), omitting the performing physician’s/supplier’s NPI in Item 32a and their details in Item 32.
- Applies to independent laboratories, hospital-leased laboratories, or any lab work performed outside a physician’s office.
Actionable Steps to Prevent/Resolve: Always ensure Item 32 contains the complete name, address, and ZIP Code of the exact location where the lab test was performed. For anti-markup services, consistently include the performing provider’s NPI in Item 32a and their identifying information in Item 32. Verify this information before submission, especially for services furnished in a facility other than the patient’s home (POS 12).
Remark Codes N264 & N286: Ordering/Referring Physician Information Missing
What Triggers N264/N286: These codes indicate a denial because the name or NPI of the referring/ordering physician, physician’s assistant, nurse practitioner, or clinical nurse specialist is absent or incorrect on the CMS 1500 form.
Common Scenarios:
- Item 17 (Name of Referring Physician or Other Source) is blank.
- Item 17a (ID number of Referring Physician) is blank or incorrect.
- Item 17b (NPI of Referring Physician) is blank or incorrect.
Actionable Steps to Prevent/Resolve: Ensure that the complete name of the ordering/referring physician is accurately entered in Item 17, along with their NPI in Item 17b, for all laboratory services. This is a critical requirement for establishing medical necessity and proper claim processing.
Remark Code MA116: Homebound Services Lacking Physician Validation
What Triggers MA116: This denial occurs when EKG tracing and specimen procurement services are provided to a patient at home or in an institution, but the claim lacks validation from the prescribing physician confirming the homebound status of the patient in Item 19.
Common Scenarios:
- Providing mobile lab or EKG services to a patient in their residence or a care facility without documenting “Homebound” or a similar annotation in Item 19.
Actionable Steps to Prevent/Resolve: For services rendered to homebound patients, always ensure that Item 19 of the CMS 1500 form explicitly states “Homebound” or provides similar clear annotation validating the patient’s status and the necessity of in-home services.
Remark Code MA120: CLIA Number Missing for Physician Office Labs
What Triggers MA120: This denial is issued when a 10-digit Clinical Laboratory Improvement Amendments (CLIA) identification number is not present in Item 23 for claims submitted by physician office laboratories.
Common Scenarios:
- A physician’s office performing lab tests but failing to include their CLIA number in the designated field on the CMS 1500 form.
Actionable Steps to Prevent/Resolve: Physician office laboratories must ensure their valid 10-digit CLIA identification number is always entered in Item 23 of the CMS 1500 form for all services performed on or after January 1, 1998. Without it, claims will be denied.
Billing EKG and Lab Specimens Together on CMS 1500
The original post mentions “EKG tracing and the procurement of specimen(s).” When billing for EKG services and laboratory specimen procurement or testing on the same CMS 1500 form, it’s essential to follow specific guidelines to prevent denials. While both can be billed, proper documentation and modifier usage are critical. Ensure the medical necessity for both services is clearly documented in the patient’s record. If a separate CPT code is used for specimen collection (e.g., 36415), it should be appropriately linked to the lab tests performed. Modifiers may be required to indicate distinct procedural services if performed at the same encounter by the same provider. Always verify payer-specific rules regarding co-billing EKG and lab services.
Distinguishing Hospital-Based vs. Independent Lab Billing on CMS 1500
The CMS 1500 form is primarily used for professional services and claims from independent laboratories. However, there are scenarios where hospital-based laboratory services can be billed on a CMS 1500. This typically applies to the professional component of outpatient hospital lab services when a physician interprets the results, or when a hospital-leased independent lab performs services. For technical components of hospital outpatient lab services, the UB-04 claim form is generally used. It’s crucial to understand this distinction: independent laboratories and physician offices typically use the CMS 1500, while most hospital-provided services (technical components) are billed on the UB-04. When a hospital-leased laboratory functions as an independent laboratory, the CMS 1500 is used, and it requires the name, address, and ZIP Code of the location where services were performed in Item 32, similar to independent labs.
Specific Payer Guidelines: Blue Cross and Blue Shield of Louisiana (PPO)
Disclaimer: The following guidelines are specific to the Preferred Care PPO network of Blue Cross and Blue Shield of Louisiana. While these principles may offer general insights, always consult individual payer policies and provider contracts for accurate billing information relevant to your specific network and state.
Using Preferred Reference Labs
Providers participating in the Preferred Care PPO network must refer members to preferred reference lab vendors for services not performed in the provider’s office. Non-adherence may result in penalties as described in provider contracts. To ensure patients receive maximum benefits, verify and use the current list of preferred reference labs, available on the BCBSLA website (www.bcbsla.com/providers >Doctor & Hospital Search).
Working With Preferred Reference Labs
Contact preferred reference labs directly for submission forms. Physicians not collecting specimens in their offices should refer PPO patients to a preferred reference lab draw site. Specimen collection billing is generally not appropriate in this situation.
Out-of-state Labs
For out-of-state reference lab referrals, the lab must be a participating provider for the member’s plan in the state where the specimen is drawn for the member to receive the highest benefits. If you collect the specimen and send it to an out-of-state lab, confirm its participation with Blue Cross and Blue Shield of Louisiana to avoid higher patient cost-shares or lower allowable charges for your practice. The location of the referring provider typically determines the service area.
Ordering Physician Requirements (BCBSLA)
The ordering/referring provider’s NPI is mandatory on all laboratory claims. Claims without this will be returned for refiling. If you are CLIA certified to provide in-office lab services and bill Blue Cross, include the ordering provider NPI information. For CMS 1500, place the NPI in Block 17B. For UB-04, Block 78. For electronic claims, 837P: 2310A loop, NM1 segment, qualifier DN in NM101; 837I: 2310D loop, NM1 segment, qualifier DN in NM101.
Scenario (BCBSLA)
If an independent laboratory in Texas processes a Louisiana member’s blood specimen drawn in Louisiana, the Texas lab should file the claim to Blue Cross and Blue Shield of Louisiana, the service area where the specimen was drawn. The Texas reference lab needs to be participating with BCBSLA for the member to receive the highest level of benefits.
Pass-Through Billing Not Permitted (BCBSLA)
Blue Cross and HMO Louisiana do not permit pass-through billing, which occurs when the ordering provider bills for a lab service they did not perform, nor was it performed by a CLIA-certified lab they own and operate. Lab claims should come from the performing provider at a CLIA-certified lab (owned/operated by ordering physician) or an in-network reference lab. You may only bill for lab services you directly perform in your office, or services performed by an employee under your direct supervision (e.g., PA, NP).
Frequently Asked Questions (FAQ)
- Are labs billed on a CMS 1500?
- Yes, independent laboratories and physician office laboratories primarily use the CMS 1500 claim form for billing professional and technical components of lab services. Hospital outpatient technical components are typically billed on a UB-04 form.
- Why did I get an MA114 denial?
- An MA114 denial often indicates that the name, address, and ZIP Code of the service location in Item 32 of the CMS 1500 form was missing or incorrect, or for anti-markup services, the performing provider’s NPI (Item 32a) and details (Item 32) were absent.
- What is medical necessity for lab tests?
- Medical necessity for lab tests means that the service is reasonable and necessary for the diagnosis or treatment of illness or injury, or to improve the functioning of a malformed body member. For Medicare, this is often defined by National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) that specify coverage criteria and frequency limits.
- Can EKG and lab specimens be billed together?
- Yes, EKG and lab specimen collection/testing can be billed together on a CMS 1500 form, provided both services meet medical necessity and are properly documented. Specific modifiers might be needed to indicate distinct services performed during the same encounter.
Source